← Back to Cibo Flash
Earnings

CF Pharmtech (02652) announced interim results

  • RevenueRMB2.1bn
  • Net profitRMB-10.5M
  • Profit attributable to ownersRMB-10.5M
  • Revenue YoY+2.1%
  • Net profit YoY-754.1%
  • Depreciation & amortisationHK$68.5M
  • Capital expenditureHK$-1.5bn
  • Interest-bearing debtHK$1.5bn

Source CF Pharmtech

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect